Skip to main content

MoneyWorks4Me

Lincoln Pharmaceuticals informs about disclosure

26 Feb 2024 Evaluate
Lincoln Pharmaceuticals has informed that it enclosed disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Patel Nishitkumar Maheshbhai.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1771.95
Dr. Reddys Labs. 1370.00
Cipla 1392.20
Lupin 2012.00
Zydus Lifesciences 1239.00
View more..